A new report from ACTION partners show that progress in involving civil society in national TB programs across the European region is falling short of planned goals
New numbers from the WHO show that 39,000 people diagnosed with drug-resistant TB are on waiting lists to get life-saving drugs – the first time such a waiting list number has been released.
From Monday onwards, Presidents and Prime Ministers will arrive in New York City for the annual United Nations General Assembly (UNGA). Among the issues they will grapple with is how to make progress on fixing a new set of development goals.
At AIDS 2014, the ACTION global health advocacy partnership will release new research assessing whether donors and affected countries are implementing World Health Organization (WHO) recommendations to address TB-HIV.
At the turn of the century when the world came together to agree the Millennium Development Goals they were articulating a vision. It was a vision that everyone in the world could understand: in the 21st century, no one should have to live in extreme poverty.
At a time of great challenges for Ukraine, 23 tuberculosis (TB) activists, representing 12 countries from the Eastern European and Central Asian region, gathered in Kyiv to collectively strengthen their ability to participate in and influence national and regional TB responses.
Fanny Voitzwinkler, coordinator of the TB Europe Coalition, discusses how the European Union can address rising rates of drug-resistant TB with its borders.